Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

ItalyBack to Italy

Clinical trials in Monserrato – page 7

178 clinical trials in Monserrato, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Monserrato at a glance
178
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

178 trials in Monserrato

Open in trial search

Squamous cell carcinoma of head and neck

Recruiting

Study of Cetuximab and Avelumab for Patients with Recurrent or Metastatic Head and Neck Cancer with PD-L1 Score 1 or Higher

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Fondazione GONO Plus

Crohn's disease

Recruiting

Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:ABBV-8736
  • Sponsor:Abbvie Deutschland GmbH & Co. KG

Psoriasis

Not yet recruiting

Study on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Janssen Cilag International

Multiple sclerosis

Not yet recruiting

Long‑Term Safety and Tolerability of Frexalimab Drug Combination in Adults with Multiple Sclerosis

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Colestyramine
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Non-small cell lung cancer

Not yet recruiting

Phase 2 Study of Oral VS-7375 in Adults with Advanced KRAS G12D‑Mutated Non‑Small Cell Lung Cancer Previously Treated

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:GFH375
  • Sponsor:Verastem Inc.

Colorectal adenocarcinoma

Not yet recruiting

A Phase 2 Study of VS-7375 Alone or with Drug Combination in Patients with Metastatic KRAS G12D‑Mutated Colorectal Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Verastem Inc.

Non-small cell lung cancer stage IV

Not yet recruiting

Osimertinib and drug combination in metastatic non‑small cell lung cancer with targetable genomic driver alterations

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Universita' Degli Studi Di Torino

Graves' disease

Not yet recruiting

A Randomized Study of Felzartamab versus Placebo to Assess Efficacy and Safety in Adults with Graves’ Disease

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Felzartamab
  • Sponsor:Biogen Idec Research Limited

Thalassaemia beta+2

Not yet recruiting

Phase 3 study of mitapivat for effectiveness and safety in children with non‑transfusion‑dependent alpha or beta thalassemia

Investigational
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Mitapivat
  • Sponsor:Agios Pharmaceuticals Inc.

Thalassaemia beta+2

Not yet recruiting

Phase 3 Study of Mitapivat to Reduce Transfusions in Children with Alpha or Beta Transfusion‑Dependent Thalassemia

Investigational
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Mitapivat
  • Sponsor:Agios Pharmaceuticals Inc.

Arrhythmic storm

Not yet recruiting

Efficacy of bupivacaine hydrochloride and lidocaine hydrochloride compared with amiodarone hydrochloride as first‑line treatment for electrical storm in patients

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Amiodarone Hydrochloride
  • Sponsor:Fondazione IRCCS Policlinico San Matteo

VEXAS syndrome

Not yet recruiting

Randomized Study of SIR9900 for Safety and Effectiveness in Patients with VEXAS Syndrome

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:SIR9900
  • Sponsor:Sironax USA Inc.

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Monserrato

What the registry says about research in the country

01 Oncology Research

Groundbreaking clinical trials focusing on colorectal cancer, breast cancer, and hepatocellular carcinoma. Studies evaluate novel targeted therapies and combination treatments for both early-stage and metastatic diseases.

  • KRAS G12C mutation treatments
  • Hormone receptor-positive breast cancer
  • Advanced colorectal adenocarcinoma

Multiple trials exploring innovative approaches to cancer treatment, including biomarker-driven therapies and immunotherapy combinations.

02 Autoimmune Conditions

Innovative research in rheumatoid arthritis and ulcerative colitis, investigating new biological therapies and treatment combinations to improve patient outcomes.

  • Molecular profiling in RA
  • Novel UC treatments
  • Systemic sclerosis studies

Focus on developing precision medicine approaches and understanding biomarker-based treatment responses.

03 Respiratory Medicine

Clinical trials examining new treatments for asthma and interstitial lung disease, with emphasis on innovative delivery systems and targeted therapies.

  • Advanced asthma treatments
  • Bronchial disease management
  • Lung volume assessments

Studies evaluate both established and novel therapeutic approaches for respiratory conditions.

Back to ItalyAll countries
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.